New painkiller designed to prevent risk of opioid addiction approved in U.S.
U.S. officials approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to ...
US FDA Approves Vertex's Non-Opioid Painkiller
(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Walmart Broccoli Recall Updated to ‘Deadly’ Risk—Here’s Why
The recalled Braga Fresh Marketside Broccoli was washed, ready-to-eat, and sold in 12-ounce bags at Walmart stores in 20 states including Alaska, Arkansas, Arizona, California, Colorado, Idaho, ...
Hosted on MSN16h
FDA approves new painkiller that shows promise and challenges of opioid alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
CNET on MSN23h
Red Dye No. 3 Can Be Found in These 9 Foods in Your Pantry
The US Food and Drug Administration has revoked its authorization of Red No. 3 in food, drinks and ingested drugs across the country after two studies showed that when laboratory rats consumed the dye ...
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
MLive15h
This chocolate recall has been upgraded to FDA’s highest risk level
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
Eagle-Tribune17h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...